FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Amna Ibrahim

Research Profile

Organizations

United States Food and Drug Administration

Activities & Behaviors

Geographic Areas

United States

Chemicals & Drugs

Disorders

Physiology

Disease Progression

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Qin Ryan; Amna Ibrahim; Martin H Cohen; John Johnson; Chia-wen Ko; R Sridhara; Robert Justice; Richard Pazdur
FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.
Amna Ibrahim; Steven Hirschfeld; Martin H Cohen; Donna J Griebel; Grant A Williams; Richard Pazdur
FDA drug approval summaries: oxaliplatin.
Amna Ibrahim; Nancy Scher; Grant Williams; R Sridhara; Ning Li; Gang Chen; John Leighton; Brian Booth; Jogarao V S Gobburu; Atiqur Rahman; Yung Hsieh; Rebecca Wood; Debra Vause; Richard Pazdur
Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Amna Ibrahim (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2008: Qin Ryan; Amna Ibrahim; Martin H Cohen; John Johnson; Chia-wen Ko; R Sridhara; Robert Justice; Richard Pazdur
FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.
The oncologist 2008;13(10):1114-9.
2004: Amna Ibrahim; Steven Hirschfeld; Martin H Cohen; Donna J Griebel; Grant A Williams; Richard Pazdur
FDA drug approval summaries: oxaliplatin.
The oncologist 2004;9(1):8-12.
2003: Amna Ibrahim; Nancy Scher; Grant Williams; R Sridhara; Ning Li; Gang Chen; John Leighton; Brian Booth; Jogarao V S Gobburu; Atiqur Rahman; Yung Hsieh; Rebecca Wood; Debra Vause; Richard Pazdur
Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2394-9.
2002: Martin H Cohen; Ramzi Dagher; Donna J Griebel; Amna Ibrahim; Alison Martin; Nancy S Scher; Gerald H Sokol; Grant A Williams; Richard Pazdur
U.S. Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acid.
The oncologist 2002;7(5):393-400.
2001: Martin H Cohen; Steven Hirschfeld; S Flamm Honig; Amna Ibrahim; John R Johnson; J J O'Leary; Robert M White; Grant A Williams; Richard Pazdur
Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene.
The oncologist 2001;6(1):4-11.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.